<?xml version="1.0"?>
<metadata xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/"><dc:title>Prognostic impact of nutritional status on overall survival and health-related quality of life in men with advanced prostate cancer</dc:title><dc:creator>Čavka,	Luka	(Avtor)
	</dc:creator><dc:creator>Pohar Perme,	Maja	(Avtor)
	</dc:creator><dc:creator>Rotovnik-Kozjek,	Nada	(Avtor)
	</dc:creator><dc:creator>Šeruga,	Boštjan	(Avtor)
	</dc:creator><dc:subject>metastatic castrate-resistant prostate cancer</dc:subject><dc:subject>nutritional risk</dc:subject><dc:subject>malnutrition</dc:subject><dc:subject>outcomes</dc:subject><dc:description>Purpose: Prognostic role of nutritional status (NS) in patients with metastatic castrate-resistant prostate cancer (mCRPC) is unknown. We hypothesized that patients’ NS at the presentation of mCRPC is prognostic for health-related quality of life (HRQoL) and overall survival (OS). Methods: We conducted a prospective observational study in mCRPC patients. At enrollment, we allocated each patient into one of four NS categories: (i) well-nourished (WN), (ii) nutritional risk without sarcopenia/cachexia (NR), (iii) sarcopenia, or (iv) cachexia. We sought the prognostic role of the NS for OS and HRQoL by regression models. Results: 141 patients were included into our study. When compared to WN patients, those with NR and cachexia had a higher chance of worse HRQoL (OR 3.45; 95% CI [1.28 to 9.09], and OR 4.17; 95% CI [1.28 to 12.5], respectively), as well as shorter OS (HR 2.04; 95% CI [1.19 to 3.39] and HR 2.9; 95% CI [1.56 to 5.41], respectively). However, when accounting for possible confounding factors, we could not prove the significant importance of NS for chosen outcomes. Conclusions: Suboptimal NS might be an unfavorable prognostic factor for HRQoL and OS. Further interventional studies focusing on therapy or prevention are warranted.</dc:description><dc:date>2023</dc:date><dc:date>2024-04-08 15:32:34</dc:date><dc:type>Članek v reviji</dc:type><dc:identifier>155619</dc:identifier><dc:identifier>UDK: 613.2</dc:identifier><dc:identifier>ISSN pri članku: 2072-6643</dc:identifier><dc:identifier>DOI: 10.3390/nu15041044</dc:identifier><dc:identifier>COBISS_ID: 142236931</dc:identifier><dc:language>sl</dc:language></metadata>
